HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

FXTAS: new insights and the need for revised diagnostic criteria.

AbstractOBJECTIVE:
Fragile X-associated tremor ataxia syndrome (FXTAS) is defined by FMR1 premutation, cerebellar ataxia, intentional tremor, and middle cerebellar peduncle (MCP) hyperintensities. We delineate the clinical, neurophysiologic, and morphologic characteristics of FXTAS.
METHODS:
Clinical, morphologic (brain MRI, (123)I-ioflupane SPECT), and neurophysiologic (tremor recording, nerve conduction studies) study in 22 patients with FXTAS, including 4 women.
RESULTS:
A total of 43% of patients had no family history of fragile X syndrome (FXS), which contrasts with previous FXTAS series. A total of 86% of patients had tremor and 81% peripheral neuropathy. We identified 3 electroclinical tremor patterns: essential-like (35%), cerebellar (29%), and parkinsonian (12%). Two electrophysiologic patterns evocative of non-length-dependent (56%) and length-dependent sensory neuropathy (25%) were identified. Corpus callosum splenium (CCS) hyperintensity was as frequent (68%) as MCP hyperintensities (64%). Sixty percent of patients had parkinsonism and 47% abnormal (123)I-ioflupane SPECT. Unified Parkinson's Disease Rating Scale motor score was correlated to abnormal (123)I-ioflupane SPECT (p = 0.02) and to CGG repeat number (p = 0.0004). Scale for the assessment and rating of ataxia correlated with dentate nuclei hyperintensities (p = 0.03) and CCS hyperintensity was a marker of severe disease progression (p = 0.04).
CONCLUSIONS:
We recommend to include in the FXTAS testing guidelines both CCS hyperintensity and peripheral neuropathy and to consider them as new major radiologic and minor clinical criterion, respectively, for the diagnosis of FXTAS. FXTAS should also be considered in women or when tremor, MCP hyperintensities, or family history of FXS are lacking. Our study broadens the spectrum of tremor, peripheral neuropathy, and MRI abnormalities in FXTAS, hence revealing the need for revised criteria.
AuthorsEmmanuelle Apartis, Anne Blancher, Wassilios G Meissner, Lucie Guyant-Maréchal, David Maltête, Thomas De Broucker, André-Pierre Legrand, Hichem Bouzenada, Hung Tran Thanh, Magali Sallansonnet-Froment, Adrien Wang, François Tison, Carole Roué-Jagot, Frédéric Sedel, Perrine Charles, Sandra Whalen, Delphine Héron, Stéphane Thobois, Alice Poisson, Gaetan Lesca, Anne-Marie Ouvrard-Hernandez, Valérie Fraix, Stephane Palfi, Marie-Odile Habert, Bertrand Gaymard, Jean-Claude Dussaule, Pierre Pollak, Marie Vidailhet, Alexandra Durr, Jean-Claude Barbot, Véronique Gourlet, Alexis Brice, Mathieu Anheim
JournalNeurology (Neurology) Vol. 79 Issue 18 Pg. 1898-907 (Oct 30 2012) ISSN: 1526-632X [Electronic] United States
PMID23077007 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Ataxia (diagnosis, genetics, physiopathology)
  • Female
  • Fragile X Syndrome (diagnosis, genetics, physiopathology)
  • Humans
  • Male
  • Middle Aged
  • Neurology (standards)
  • Parkinsonian Disorders (diagnosis, genetics, physiopathology)
  • Peripheral Nervous System Diseases (diagnosis, genetics, physiopathology)
  • Practice Guidelines as Topic (standards)
  • Tremor (diagnosis, genetics, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: